arrow_back Trending Legislation
Share share

Support for Rare Cancer Day: Boosting Awareness and Better Treatment

This House Resolution supports designating September 30 as Rare Cancer Day. The aim is to highlight challenges faced by rare cancer patients and promote early diagnosis and effective treatment. Citizens may benefit from increased awareness and potentially improved access to diagnosis and therapies.
Key points
Designating Rare Cancer Day aims to increase public awareness of these diseases.
Emphasizes the need for early detection and development of more effective treatments for rare cancers.
Supports dedicating funding for rare cancer research, potentially leading to new therapies.
article Official text account_balance Process page notifications_active Track this Bill
gavel
Status:
Expired
Record your position for audit.
Why does your vote on bills matter?
It creates raw, undeniable proof. Civic Will provides the permanent data to verify the Government's loyalty towards its citizens (explained here). Start recording it now.
Additional Information
Expressing support for the designation of September 30, 2023, as "Rare Cancer Day" to highlight the challenges patients with rare cancers face and to raise awareness and support efforts to improve early diagnosis and treatment.
Print number: HRES 725
Sponsor: Rep. Kelly, Mike [R-PA-16]
Process start date: 2023-09-26
System Note: Lustra is free, publicly auditable civic infrastructure, with full source code available on GitHub. You are reading sterilized legislative data, processed by our radical neutrality engine to strip political spin and retain factual mechanics. We process only official government data. Original documents remain the authoritative source, always verify them if you can.
Summarized by: gemini-2.5-flash-preview-05-20
Source data: api.congress.gov
AI work logs for this document launch
Summary & Status

Key Questions about Support for Rare Cancer Day: Boosting Awareness and Better Treatment

A structured overview of the legislative process, official sources, status and civic context.

What is the official ID of this bill?

The official print number for this legislation is HRES 725.

Which chamber initiated this legislation?

This legislation was initiated in the House of Representatives.

When did the legislative process begin?

The process officially started on 2023-09-26.

What are the main provisions?

Key points include:

  • Designating Rare Cancer Day aims to increase public awareness of these diseases.
  • Emphasizes the need for early detection and development of more effective treatments for rare cancers.
  • Supports dedicating funding for rare cancer research, potentially leading to new therapies.

What is the specific legal status?

The current status is Expired.

Where can I read the full text of this legislation?

The full official text is available at: View full text

Who is the primary sponsor?

The primary sponsor is Rep. Kelly, Mike [R-PA-16].

What is the latest detailed status?

The latest detailed status is: Referred to the Subcommittee on Health.

Is this summary verified?

Yes. This content was analyzed by AI and verified by the Lustra Judge System on 2025-12-24.

Analysis and Potential Impact of HRES 725

We don't know, that is up to you to decide. Summarizing raw data with AI is fundamentally different from predicting socio-economic outcomes. As of 2026, we believe impact assessment strictly requires a human in the loop to verify and judge. Review our public AI processing logs for full transparency, and use Lustra to track active legislation for instant status push notifications.

CATEGORIES

Health